Clinical Expertise

Dr. Tuchman spends half of his time caring for patients with multiple myeloma and other plasma cell disorders, and the other half of his time performing clinical research. His specific research interests include 1) investigating therapeutic approaches for patients who are vulnerable to toxicity from therapy due to advanced age or other medical problems, 2) novel therapies including immunotherapies such as chimeric antigen receptor – T cells (CAR-T), and 3) therapeutic approaches to rarer myeloma-related conditions such as amyloidosis. Dr. Tuchman is an active member of expert groups such as the International Myeloma Working Group, his work has been supported by NIH, foundation and industry grants, and he is widely published in leading oncology and hematology journals.

About

MEDICAL SCHOOL

Georgetown University, 1998 - 2003
Honors: Summa Cum Laude, Thomas M. Kelliher Award for Excellence

FELLOWSHIP

Duke University Medical Center
Area: Hematology and Medical Oncology

RESIDENCY AND CHIEF RESIDENCY

Duke University Medical Center
Area: Internal Medicine

MASTER OF HEALTH SCIENCE

Duke University, 2008 - 2016
Area: Clinical Research Training Program
Honors: Eugene Stead Teaching Attending Physician, American Society of Clinical Oncology Merit Award

CERTIFICATIONS

Internal Medicine, Board Certified
Internal Medicine-Hematology, Board Certified
Internal Medicine-Medical Oncology, Board Certified

Location

Chapel Hill Comprehensive Cancer Center: Physicians Office Bldg, 170 Manning Dr #7305, Chapel Hill, NC 27599, USA

Sascha A. Tuchman, MD, MHS

Director, Multiple Myeloma and Amyloidosis Program. Associate Professor, University of North Carolina – Chapel Hill Comprehensive Cancer Center

Clinical Expertise